Drug-Coated Balloon in Primary Percutaneous Coronary Intervention

Drug-Coated Balloon in Primary Percutaneous Coronary Intervention

According to the latest coronary interventional guidelines, a drug-eluting stent is the recommended reperfusion therapy in primary percutaneous coronary intervention (pPCI). However, deficiencies and defects, such as in-stent restenosis (ISR), incomplete stent apposition, stent thrombosis, reinfarct...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hui Zhao, Runran Miao, Fei Lin, Guoan Zhao
Format:	Article
Language:	English
Published:	Wiley 2023-01-01
Series:	Journal of Interventional Cardiology
Online Access:	http://dx.doi.org/10.1155/2023/5210808
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Drug-coated balloons in percutaneous coronary interventions: existing evidence and emerging hopes
by: Aleksandra Gąsecka, et al.
Published: (2025-06-01)

Case Report: Trissing balloon inflation and percutaneous coronary intervention with drug-coated balloons for the treatment of restenosis of a left main trifurcation lesion
by: Francesco Amata, et al.
Published: (2025-05-01)

Drug coated balloons in percutaneous coronary intervention: how can computational modelling help inform evolving clinical practice?
by: Silvia Renon, et al.
Published: (2025-04-01)

Clinical outcomes of stent-less percutaneous coronary intervention with intravascular lithotripsy and drug-coated balloon for severely calcified de novo coronary lesions
by: Toru Misawa, et al.
Published: (2025-08-01)

Drug-coated Balloons for Small Coronary Vessel Interventions: A Literature Review
by: Thomas Nestelberger, et al.
Published: (2019-11-01)

Effect of enhanced external counterpulsation on the rehabilitation of patients with acute myocardial infarction after drug-coated balloon-based percutaneous coronary intervention
by: Xiaojiao Hao, et al.
Published: (2025-04-01)

Paclitaxel-Coated Versus Sirolimus-Coated Eluting Balloons for Percutaneous Coronary Interventions: Pharmacodynamic Properties, Clinical Evidence, and Future Perspectives
by: Filippo Luca Gurgoglione, et al.
Published: (2024-11-01)

The Efficacy of Drug-Coated Balloon for Acute Coronary Syndrome
by: Hirokazu Naganawa, et al.
Published: (2023-01-01)

Expanding the Role of Drug‐Coated Balloons in Contemporary Percutaneous Coronary Intervention: Start of the Next Revolution or Just One More Weapon in a Growing Arsenal?
by: Sandeep Nathan
Published: (2025-06-01)

Effects of Drug-Coated Balloons on Inflammatory Cytokines After Interventional Therapy for Coronary Artery Calcification
by: Jiaming Yu, et al.
Published: (2024-01-01)

Coronary Artery Aneurysm Post Drug-Coated Balloon Angioplasty
by: Aninka Saboe, MD, et al.
Published: (2025-07-01)

Role of Drug-coated Balloons in Small-vessel Coronary Artery Disease
by: Michael Megaly, et al.
Published: (2019-01-01)

Advances in drug-coated balloons for the treatment of coronary artery de novo large-vessel lesions
by: Lizhi Lin, et al.
Published: (2025-06-01)

Drug Coated Balloon-Only Strategy in De Novo Lesions of Large Coronary Vessels
by: Mark Rosenberg, et al.
Published: (2019-01-01)

Expanding the Role of Drug-Coated Balloons in Treating De Novo Coronary Artery Disease
by: Anna van Veelen, MD, PhD, et al.
Published: (2025-01-01)

Efficacy of Low-Pressure Inflation of Oversized Drug-Coated Balloon for Coronary Artery Disease
by: Katsumi Ueno, et al.
Published: (2020-01-01)

Successful management of coronary artery perforation with drug-coated balloon: a case report
by: Bi-hua Li, et al.
Published: (2024-11-01)

Research status and trends of drug-coated balloons in coronary artery disease: a bibliometric analysis
by: Yue Yu, et al.
Published: (2025-08-01)

HOW EFFECTIVE ARE ANTITHROMBOTIC THERAPIES IN PRIMARY PERCUTANEOUS CORONARY INTERVENTION
Published: (2016-03-01)

Balloon Deflation Strategy during Primary Percutaneous Coronary Intervention in Acute ST-Segment Elevation Myocardial Infarction: A Randomized Controlled Clinical Trial and Numerical Simulation-Based Analysis
by: Jun Gu, et al.
Published: (2020-01-01)

Drug-coated balloons versus drug-eluting stents in patients with small coronary artery disease: an updated meta-analysis
by: Ahmed Abdelaziz, et al.
Published: (2025-04-01)

Drug coated balloons for coronary artery bifurcation lesions: A systematic review and focused meta-analysis.
by: Natasha H Corballis, et al.
Published: (2021-01-01)

Leaving Nothing Behind: Expanding the Clinical Frontiers of Drug-Coated Balloon Angioplasty in Coronary Artery Disease
by: Marcello Marchetta, et al.
Published: (2025-05-01)

Monocyte distribution width enhances the detection of infection in patients after primary percutaneous coronary intervention
by: Sheng-Feng Lin, et al.
Published: (2025-01-01)

Entrapment of Unraveled Coronary Guidewire in Right Coronary Artery during Primary Percutaneous Coronary Intervention
by: Mehrpooya Maryam, et al.
Published: (2025-01-01)

Drug-coated balloon dilation for female urethral stricture
by: Hannah S. Thomas, et al.
Published: (2025-03-01)

Drug-Coated Balloons: Recent Evidence and Upcoming Novelties
by: Zaid Mohammad Fahmi Shahrori, et al.
Published: (2025-05-01)

Organoprotective Eﬀects of Extracorporeal Membrane Oxygenation and Intra-Aortic Balloon Pump in High-Risk Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome
by: R. A. Kornelyuk, et al.
Published: (2020-03-01)

Debulking plus drug-coated balloon angioplasty versus drug-coated balloon angioplasty alone for femoropopliteal Tosaka III in-stent restenosis lesions
by: Liqiang Li, et al.
Published: (2022-09-01)

Long term outcomes of drug-coated balloons versus drug-eluting stents in patients with small vessel coronary artery disease
by: Hesham Refaat, et al.
Published: (2025-07-01)

Predictors of optimal angiographic lesion outcomes in drug-coated balloon treatment for de novo coronary artery disease
by: Dong Oh Kang, et al.
Published: (2025-03-01)

CARDIOPROTECTION DURING PRIMARY PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH MYOCARDIAL INFARCTION
by: IVAN E. Vereschagin, et al.
Published: (2017-12-01)

Clinical value of drug-coated balloon versus second-generation drug-eluting stent for de novo lesions in large coronary arteries: insights from the real world
by: Kang Zhao, et al.
Published: (2024-12-01)

Analysis of drug gene detection after intracranial drug-coated balloon operation
by: Wu Mingxin, et al.
Published: (2025-05-01)

Impact of drug eluting stents’ length and diameter on short term outcome in patients undergoing primary percutaneous coronary intervention
by: Abdel-Galeel Ahmed, et al.
Published: (2025-03-01)

Treatment of In-Stent Restenosis by Excimer Laser Coronary Atherectomy and Drug-Coated Balloon: Serial Assessment with Optical Coherence Tomography
by: Toru Miyazaki, et al.
Published: (2019-01-01)

In-Stent Restenosis and a Drug-Coated Balloon: Insights from a Clinical Therapeutic Strategy on Coronary Artery Diseases
by: Dai-Min Zhang, et al.
Published: (2020-01-01)

Efficacy and long-term outcomes of drug coated balloon in de novo lesions of small versus large coronary vessels
by: Hesham Refaat, et al.
Published: (2025-05-01)

Drug-Coated Balloon-Only Angioplasty Outcomes in Diabetic and Nondiabetic Patients with De Novo Small Coronary Vessels Disease
by: Botey Katamu Benjamin, et al.
Published: (2021-01-01)

Predictors for quantitative flow ratio loss in patients with de novo coronary artery disease treated with drug-coated balloons
by: Yunhui Zhu, et al.
Published: (2025-07-01)